tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

VCNX Stock Latest News

Vaccinex to report new clinical data on pepinemab in enhancing immunotherapy
The FlyVaccinex to report new clinical data on pepinemab in enhancing immunotherapy
20d ago
VCNX
Vaccinex Delays Yearly Report Filing
PremiumCompany Announcements
Vaccinex Delays Yearly Report Filing
1M ago
VCNX
Vaccinex to delist common stock from Nasdaq
PremiumThe Fly
Vaccinex to delist common stock from Nasdaq
2M ago
VCNX
Vaccinex receives delisting notification from Nasdaq
PremiumThe Fly
Vaccinex receives delisting notification from Nasdaq
5M ago
VCNX
Vaccinex reports Q3 EPS ($2.83) vs. ($15.25) last year
PremiumThe Fly
Vaccinex reports Q3 EPS ($2.83) vs. ($15.25) last year
6M ago
VCNX
Vaccinex provides update on ActivMAb platform
PremiumThe FlyVaccinex provides update on ActivMAb platform
6M ago
VCNX
Vaccinex to preset new biomarker data on HNSCC
Premium
The Fly
Vaccinex to preset new biomarker data on HNSCC
6M ago
VCNX
Vaccinex reports new findings from SIGNAL-AD Phase 1b/2 trial of pepinemab
Premium
The Fly
Vaccinex reports new findings from SIGNAL-AD Phase 1b/2 trial of pepinemab
6M ago
VCNX
Vaccinex announces it will present new data for Phase 1b/2 SIGNAL-AD study
PremiumThe Fly
Vaccinex announces it will present new data for Phase 1b/2 SIGNAL-AD study
7M ago
VCNX
Vaccinex files to sell 1.6M shares of common stock for holders
PremiumThe Fly
Vaccinex files to sell 1.6M shares of common stock for holders
7M ago
VCNX
Vaccinex announces exercise of warrants for $6.2M in gross proceeds
PremiumThe Fly
Vaccinex announces exercise of warrants for $6.2M in gross proceeds
8M ago
VCNX
Vaccinex Director Chrystyna Bedrij Stecyk Abruptly Resigns
PremiumCompany Announcements
Vaccinex Director Chrystyna Bedrij Stecyk Abruptly Resigns
8M ago
8K
VCNX
Vaccinex Provides Update on Alzheimer’s Treatment Trial
PremiumCompany AnnouncementsVaccinex Provides Update on Alzheimer’s Treatment Trial
9M ago
8K
VCNX
Vaccinex provide update on findings for SIGNAL-AD Phase 1b/2 trial of pepinemab
Premium
The Fly
Vaccinex provide update on findings for SIGNAL-AD Phase 1b/2 trial of pepinemab
9M ago
VCNX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
9M ago
CNSP
CORT
Vaccinex trading resumes
PremiumThe Fly
Vaccinex trading resumes
9M ago
VCNX
Vaccinex trading halted, volatility trading pause
PremiumThe Fly
Vaccinex trading halted, volatility trading pause
9M ago
VCNX
Vaccinex reports data for SIGNAL-AD Phase 1b/2 trial of pepinemab
PremiumThe Fly
Vaccinex reports data for SIGNAL-AD Phase 1b/2 trial of pepinemab
9M ago
VCNX
Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab
PremiumThe Fly
Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab
10M ago
VCNX
Vaccinex files to sell 490,509 shares of common stock for holders
PremiumThe FlyVaccinex files to sell 490,509 shares of common stock for holders
11M ago
VCNX
Vaccinex Completes Key Study Phase for Alzheimer’s Drug
Premium
Company Announcements
Vaccinex Completes Key Study Phase for Alzheimer’s Drug
11M ago
8K
VCNX
Vaccinex reports completion of last patient visit in SIGNAL-AD Phase 1b/2 study
Premium
The Fly
Vaccinex reports completion of last patient visit in SIGNAL-AD Phase 1b/2 study
11M ago
VCNX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >